Seismic Therapeutic raises $121m to advance ML-optimised immunology pipeline
The proceeds from the funding round will be used by the company to advance the Phase 1 proof-of-mechanism…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Dec 23
The proceeds from the funding round will be used by the company to advance the Phase 1 proof-of-mechanism…
29 Nov 23
AWS will help Amgen discover, develop, and boost the production throughput of medicines and increase sustainability and operational…
29 Nov 23
Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics technology
28 Nov 23
Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…
28 Nov 23
CEO Frederic Revah discusses how Artificial Intelligence is creating next-generation gene therapy vectors and reducing bioproduction costs in…
23 Nov 23
The company has designed an AI stack to detect new therapeutic targets and forecast responses of patients to…
22 Nov 23
The partnership is intended to improve Genentech's advanced AI research programmes by converting its generative AI models and…
21 Nov 23
Research aims to employ RION's exosome technology platform to better understand regenerative medicine in war zones for pulmonary…
14 Nov 23
Under the agreement, Aitia will deploy Charles River's Logica across its portfolio of novel drug targets to optimise…
10 Nov 23
The partnership will combine Recursion’s artificial intelligence (AI)-guided drug discovery platform with Bayer’s small molecule compound library and…